BioSpectrum Asia - July 2020
BioSpectrum Asia - July 2020
Obtén acceso ilimitado con Magzter ORO
Lea BioSpectrum Asia junto con 8,500 y otras revistas y periódicos con solo una suscripción Ver catálogo
1 mes $9.99
1 año$99.99
$8/mes
Suscríbete solo a BioSpectrum Asia
1 año $10.99
Guardar 7%
comprar esta edición $0.99
En este asunto
Firms racing to develop antibody treatment for COVID-19
The Coronavirus COVID-19 has raged the world and has infected 8,993,659 cases and killed 469,587 (as of June 23, 2020. Source World Health Organization (WHO)). Pharma firms, scientists and governments all over the world are racing to find a cure for the virus. The entire world is waiting for the vaccine; Moderna’s mRNA vaccine will begin phase III study in July. Amidst all this, some biopharma companies are pushing to develop antibody based treatments for the virus. Does that have any merit? Why are firms putting billions of dollars into it when vaccines are the ultimate solution? Let’s find out.
Daiichi Sankyo enters research collaboration for COVID-19
The University of Tokyo, RIKEN, Nichi-Iko Pharmaceutical and Daiichi Sankyo in Japan have reached a basic agreement on collaborative R&D on a Nafamostat inhalation formulation for the treatment of novel coronavirus infection.
1 min
Firms Racing To Develop Antibody Treatment For Covid-19
The Coronavirus COVID-19 has raged the world and has infected 8,993,659 cases and killed 469,587 (as of June 23, 2020. Source World Health Organization (WHO)). Pharma firms, scientists and governments all over the world are racing to find a cure for the virus. The entire world is waiting for the vaccine; Moderna’s mRNA vaccine will begin phase III study in July. Amidst all this, some biopharma companies are pushing to develop antibody-based treatments for the virus. Does that have any merit? Why are firms putting billions of dollars into it when vaccines are the ultimate solution? Let’s find out.
10+ mins
Controversial papers in NEJM and The Lancet - A KNEE-JERKER DURING PANDEMIC?
Praised as a potential miracle cure, hundreds of trials got initiated across the globe for HCQ. Scientists started trying the drugs in low and high doses; alone or combined with other drugs in patients with mild or severe disease. But this hope recently got struck by a big blow when a study came along claiming that these antimalarial drugs not only look ineffective, but are downright deadly.
10 mins
So Far Covid-19 Has Limited Impact On Our Business
Established by Dr Samantha Du in 2014, China-based Zai Lab, a biopharmaceutical company, has an impressive track record.
4 mins
“Investment will flow towards digital solutions to augment treatment”
In 2017, Dr Ruchir Mehra, Harsh V Bansal, and Richeek Arya, came together and started Remedo as a digital engagement platform to help doctors effectively manage their patients with chronic diseases, providing end-to-end care in their recovery process.
4 mins
“We see already a higher awareness of why life science needs to be a priority for Japan and Australia”
Cytiva (formerly part of GE Healthcare Life Sciences), a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics, has joined hands with Takara Bio to manufacture a DNA vaccine candidate for COVID-19.
4 mins
BioSpectrum Asia Magazine Description:
Editor: MM Activ Sci-Tech Communication
Categoría: Business
Idioma: English
Frecuencia: Monthly
BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:
* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.
BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.
- Cancela en cualquier momento [ Mis compromisos ]
- Solo digital